Skip to main content
Back to Trials
NCT07475728Recruiting

EMS-Initiated Buprenorphine

Yale University

Start Date

5/21/2026

Completion Date

5/1/2029

Summary

This is a multisite EMS study that will first conduct a sequence of pragmatic, prehospital field studies to provide preliminary feasibility, acceptability, and safety data for refinement and enhancement of a subsequent single-arm prospective trial that will provide preliminary effectiveness data, from which to build a larger randomized control trail (RCT) trial.

Detailed Description

Evaluating the EMS clinical protocol details and subsequent research procedures will be accomplished by enrolling approximately five EMS-initiated BUP encounters per site. Subsequently, a pragmatic field study will engage approximately thirty successful BUP initiations to assess the feasibility, acceptability, and safety of the EMS clinical protocol and follow up procedures. Investigators will also enroll a cohort of up to thirty patients per site who are eligible for BUP but refuse for informative purposes only, to understand reasons for refusal. Qualitative data on the refusal cohort will be analyzed separately. The outcomes of the pragmatic studies will inform revisions to the EMS clinical protocol. A single-arm prospective trial of approximately 100 patients per site will subsequently be conducted to collect preliminary data on the effectiveness of EMS-initiated BUP on engagement in MOUD treatment within 10 and 30 days after the EMS-initiated BUP encounter.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * 18 years of age or older * Treated by the EMS-Initiated buprenorphine clinical protocol which includes: Patients that accept EMS-Initiated BUP protocol. Patients offered the EMS-Initiated BUP protocol but declined.1 * Willing to follow study procedures. * Able to speak English sufficiently to understand study procedures, and to provide verbal and electronic/written consent. Exclusion Criteria: * Patients who lack decision making capacity * Patients who are in police or protective custody

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Opioid Use Disorder

Locations

Alameda Health System

Oakland, California 94602

United States

Hennepin Healthcare

Minneapolis, Minnesota 55415

United States

Cooper University Hospital

Camden, New Jersey 08103

United States